Healthcare Pharmaceutical Biotech

Invitation to Presentations of Senzime's Second Quarter 2026 Report

July 13, 2026 6:15 AM

Senzime (STO:SEZI)(OTCQX:SNZZF) invites investors, analysts, and media to presentations of the second quarter report for 2026 on July 16. The report will be published at 08:00 am CEST the same day. Philip Siberg, CEO of Senzime, will present the report through a webcast that can be seen from 09:00 am CEST on Senzime's website senzime.com/investors. A Live Q&A, hosted by Gustaf Meyer, analyst at Redeye, will be aired at 10:00 am CEST via Redeyes...

Read more

Nanografi Increases Click-Through Rates and Scientific Engagement With Bioz

July 13, 2026 4:00 AM

Bioz, the company transforming scientific publications into product credibility, announced its collaboration with Nanografi, a global provider of advanced nanomaterials, graphene products, and laboratory technologies supporting scientific innovation across academia and industry. Through the implementation of Bioz Badges, Nanografi is enhancing how researchers discover and engage with publication-backed validation directly within the digital...

Read more

Genflow Biosciences PLC Announces Mid-Year Operational and Corporate Summary

July 13, 2026 2:00 AM

Genflow Biosciences Plc (LSE:GENF)(OTCQB:GENFF) ("Genflow" or the "Company"), an emerging leader in the field of longevity research, provides a mid-year operational and corporate summary covering the six-month period to 30 June 2026. No delays in the dog clinical trial: Positive preliminary interim results from the SLAB trial, followed by confirmation of sustained safety and efficacy at the three-month follow-up Expansion of confidentiality...

Read more

Ascelia Pharma Provides Orviglance Update

July 12, 2026 1:00 PM

Ascelia Pharma (STO:ACE) - Ascelia Pharma AB (publ) (STO:ACE), a biopharmaceutical company focused on improving the lives of people living with rare cancer conditions, provides an update following the recent publication of the Complete Response Letter (CRL) by the U.S. Food and Drug Administration (FDA) regarding the New Drug Application (NDA) for Orviglance®. As previously communicated, Ascelia Pharma ("Ascelia") is preparing for a Type A...

Read more

MMJ The Voice DEA Didn't Want to Hear From During Marijuana Rescheduling Hearings

July 12, 2026 10:15 AM

The most revealing moment of the DEA's marijuana rescheduling process may not have occurred during seven days of testimony in Arlington. It occurred weeks earlier, when the DEA decided who would not be allowed into the hearing room. The agency excluded MMJ International Holdings-the only company developing botanical cannabinoid medicines through the FDA's formal drug approval process-from participating in a hearing whose central question was...

Read more

Zevay GLP-1 Review 2026: Could This Lower-Cost Telehealth Option Be the Right Fit for Your Weight-Management Goals?

July 11, 2026 9:10 PM

Quick disclosure before you dive in: this is a paid advertorial, and a commission is earned if you purchase through links in this article. Product and program claims come from Zevay, LLC and aren't independently endorsed here. Zevay is a technology platform, not a medical practice or pharmacy - prescription medication is available only after an independent, licensed provider reviews and approves you, and approval isn't guaranteed. The compounded...

Read more

ProstaCleanse Reviews and Complaints: Is This Once-Daily Prostate Support Upgrade What Men Have Been Looking For?

July 11, 2026 4:15 PM

Quick disclosure before you read further: this is a paid advertorial, and a commission is earned if you purchase through links in this article. Product claims are attributed to the brand, not independently endorsed. ProstaCleanse is a dietary supplement - not a drug, not FDA-approved, and not intended to diagnose, treat, cure, or prevent any disease. Official site: prostacleanse.org. ProstaCleanse Reviews & Complaints 2026: Researching What...

Read more

RNK Health NAD+ Reviews and Complaints 2026: Is This the At-Home Longevity Upgrade That Finally Fits a Modern Wellness Routine?

July 11, 2026 3:05 PM

Quick disclosure before you dive in: this is a paid advertorial, and a commission is earned if you purchase through links in this article. Product claims are attributed to the brand and aren't independently endorsed. Prescription medication available only after consultation and approval by a licensed healthcare provider, if clinically appropriate. Approval is not guaranteed. Compounded medications are not FDA-approved and are not reviewed by FDA...

Read more

TrimRX GLP-1 Reviews & Complaints (2026) Comprehensive Online GLP-1 Weight Loss Care Program Evaluation

July 11, 2026 11:55 AM

Title phrases including "Reviews & Complaints" reflect this article's own sponsored publishers editorial framing, not an external investigation or regulatory action. Advertorial - Sponsored Consumer Information. This is a paid advertorial, and a commission is earned if you purchase through links in this article. Program claims are attributed to the brand and are not independently endorsed. TrimRx is the platform - not a prescriber, not a...

Read more

PureNail Pro Reviews & Complaints (2026) Getting to Know the Pure Nail Pro Toenail Fungus Formula Before Buy

July 10, 2026 9:45 PM

This title, including the phrase "Toenail Fungus Formula," reflects the client's editorial title selection and the brand's own product positioning at thepurenailpro.com - not an independent claim by this publication that the product treats, cures, or eliminates a fungal infection. "Reviews & Complaints" is a review-format convention; "Complaints" refers to documented inconsistencies, not a verified volume of formal complaints. Quick disclosure:...

Read more

Marijuana Rescheduling Worth a Billion Dollars in Forgiven Taxes To MSO's Plus More Than Two Billion Annual Tax Savings

July 10, 2026 9:35 PM

On July 2, the Justice Department told the D.C. Circuit that the two parties seeking a stay of the Marijuana Rescheduling Order-a drug-testing association and MMJ International Holdings-"invoke pocketbook interests." The accusation deserves a serious answer, because the government has the ledger pointed in the wrong direction. If the court wants to know who has a financial stake in the outcome of this case, it should look at the parties the...

Read more

NeuroPeak Reviews & Complaints (2026) Scientific Ingredient Research Disclosed for Neuro Peak Formula

July 10, 2026 9:25 PM

Title phrases including "Scientific Ingredient Research Disclosed" are client-required wording, drawn from language published on NeuroPeak's own checkout site. This publication does not independently substantiate them. Readers seeking the full explanation should continue reading, including the glossary section below. Quick disclosure before you read further: this is a paid advertorial, and this content is promotional in nature, intended for...

Read more

TrimX Drops Reviews and Complaints 2026: Is This Liquid Metabolism Support the Easier Daily Upgrade Buyers are Rechecking Before Ordering?

July 10, 2026 8:15 PM

Quick heads-up before we dive in: this is a paid advertorial, and a commission is earned if you buy through a link here. Everything below is attributed to the brand, not asserted as this article's own finding - and like any dietary supplement, TrimX Drops isn't a drug, isn't FDA-approved, and isn't meant to diagnose, treat, cure, or prevent anything. Everything here reflects brand materials and the product label as reviewed in July 2026, so...

Read more

Onco-Innovations Completes Analytical Reference Standard Preparation Program for ONC010’s API

July 10, 2026 6:00 PM

Onco-Innovations Limited (CBOE CA:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H, WKN: A3EKSZ) ("Onco" or the "Company") announces the successful completion of its analytical reference standard preparation program for A83B4C63, the active pharmaceutical ingredient ("API") supporting the Company's lead oncology program, ONC010 (the "PNKP Inhibitor Technology"). The reference standard program, which was completed in collaboration with Dalton Pharma Services,...

Read more

ADM Tronics Reports Fiscal Year 2026

July 10, 2026 4:52 PM

ADM Tronics Unlimited, Inc. (OTCQB:ADMT), a technology-based developer and manufacturer of innovative technologies, products, and proprietary medical devices, announces results for fiscal year ended March 31, 2026. During the fiscal year ended March 31, 2026, ADM Tronics continued to advance the development of the human medical version of its proprietary Sonotron® technology. This initiative targets one of healthcare's largest unmet needs-the...

Read more

Revelation Biosciences Announces Adoption of Stockholder Rights Plan

July 10, 2026 4:05 PM

Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or "Revelation"), a clinical-stage life sciences company developing innovative solutions to treat acute and chronic disease, today announced that its Board of Directors (the "Board") has adopted a stockholder rights plan (the "Rights Plan") and declared a dividend distribution of one right (a "Right") for each outstanding share of the Company's common stock. The Rights Plan was adopted...

Read more

SPIN Magazine Features Ten Celebrities and Their Ayahuasca Journeys at Rythmia

July 10, 2026 1:30 PM

A new feature in SPIN Magazine profiles ten celebrities who traveled to Rythmia Life Advancement Center for ayahuasca, and details how the experience reshaped their lives. The story arrives as psychedelic healing continues its move into the mainstream, showing up across television, film, and music, and in candid testimonials from public figures willing to talk on the record. Among the ten featured are Southern Charm's Shep Rose, who wrote a...

Read more

Nursing Home Abuse Center Launches Free Nursing Home Neglect Screening Tool for Families

July 10, 2026 12:44 PM

The Nursing Home Abuse Center has launched its free, 3-minute, 5-question screening tool for anyone concerned about nursing home neglect. This rapid online assessment helps families recognize potential signs of neglect. It's available on the organization's website and requires no registration or personal information to access. Nursing home neglect remains one of the most underreported and misunderstood problems in long-term care. Families who...

Read more

Qure.ai Strengthens North America Leadership Team to Accelerate U.S. Expansion

July 10, 2026 12:43 PM

Qure.ai today announced the promotion of Amy Casey, a former Microsoft and Nuance leader, to Executive Vice President of Sales for North America and the appointment of Malika Shrivastava, a former Google executive, as its first Chief Marketing Officer, strengthening its leadership team as the company scales its commercial operations to meet growing demand for healthcare AI in the United States. Qure.ai expands its North American commercial...

Read more

Hopelessness Is Rising Around the World. Science Says We Can Solve It, and on July 12, We Begin

July 10, 2026 12:35 PM

Somewhere today, a teenager will stop believing tomorrow can be better. She is not alone: more than half of US teen girls report persistent sadness or hopelessness, and hopelessness predicts loneliness, anxiety, depression, violence, self-harm, and suicide. But new peer-reviewed research delivers stunning news: Hope is not a personality trait or a lucky break. It is a skill, it is teachable, and this is a crisis we can solve. That is why iFred,...

Read more